These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11432396)

  • 1. Fabry disease: enzymatic diagnosis in dried blood spots on filter paper.
    Chamoles NA; Blanco M; Gaggioli D
    Clin Chim Acta; 2001 Jun; 308(1-2):195-6. PubMed ID: 11432396
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for Fabry disease in patients with left ventricular hypertrophy.
    Mawatari K; Yasukawa H; Oba T; Nagata T; Togawa T; Tsukimura T; Kyogoku S; Ohshima H; Minami T; Sugi Y; Sakuraba H; Imaizumi T
    Int J Cardiol; 2013 Aug; 167(3):1059-61. PubMed ID: 23168011
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of two tests for serum alpha-galactosidase in nonneuromuscular left ventricular hypertrabeculation/concompaction.
    Finsterer J; Stöllberger C; Voigtländer T
    Jpn Heart J; 2004 Jan; 45(1):179-81. PubMed ID: 14973364
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoquantification of alpha-galactosidase: evaluation for the diagnosis of Fabry disease.
    Fuller M; Lovejoy M; Brooks DA; Harkin ML; Hopwood JJ; Meikle PJ
    Clin Chem; 2004 Nov; 50(11):1979-85. PubMed ID: 15364892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fabry disease: enzymatic screening using dried blood spots on filter paper].
    Caudron E; Germain DP; Prognon P
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S263-9. PubMed ID: 21211677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic diagnosis of Fabry disease using a fluorometric assay on dried blood spots: An alternative methodology.
    Caudron E; Prognon P; Germain DP
    Eur J Med Genet; 2015 Dec; 58(12):681-4. PubMed ID: 26520229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heart in Anderson Fabry disease.
    Kampmann C; Wiethoff CM; Perrot A; Beck M; Dietz R; Osterziel KJ
    Z Kardiol; 2002 Oct; 91(10):786-95. PubMed ID: 12395219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Fabry's disease: an unusual cause of left ventricular hypertrophy.
    Nunes JP; Costa O; Faria Mdo S; Almeida PB; Lacerda L
    Nat Clin Pract Cardiovasc Med; 2007 Nov; 4(11):630-3. PubMed ID: 17957210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isolated left ventricular hypertrophy : is it a Fabry disease?].
    Barbey F; Dormond O; Monzambani V; Barbey G; Namdar M; Monney P
    Rev Med Suisse; 2020 Oct; 16(709):1886-1890. PubMed ID: 33026733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced filter paper enzyme assay for high-throughput population screening for Fabry disease.
    Poeppl AG; Murray GJ; Medin JA
    Anal Biochem; 2005 Feb; 337(1):161-3. PubMed ID: 15649390
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diffuse Fabry's angiokeratoma].
    Trofimova IB; Aĭvazian AA
    Vestn Dermatol Venerol; 1983 Jan; (1):54-7. PubMed ID: 6299021
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS study.
    Hagège AA; Caudron E; Damy T; Roudaut R; Millaire A; Etchecopar-Chevreuil C; Tran TC; Jabbour F; Boucly C; Prognon P; Charron P; Germain DP;
    Heart; 2011 Jan; 97(2):131-6. PubMed ID: 21062768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabry disease presenting as apical left ventricular hypertrophy in a patient carrying the missense mutation R118C.
    Caetano F; Botelho A; Mota P; Silva J; Leitão Marques A
    Rev Port Cardiol; 2014 Mar; 33(3):183.e1-5. PubMed ID: 24661928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between alpha-galactosidase A activity in blood samples collected on filter paper, leukocytes and plasma.
    Daitx VV; Mezzalira J; Goldim MP; Coelho JC
    Clin Biochem; 2012 Oct; 45(15):1233-8. PubMed ID: 22569598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fabry disease: a little-known metabolic disorder with severe consequences].
    Jansen T; Grabbe S
    MMW Fortschr Med; 2006 Nov; 148(48):46-7. PubMed ID: 17615772
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for Fabry disease in left ventricular hypertrophy: documentation of a novel mutation.
    Baptista A; Magalhães P; Leão S; Carvalho S; Mateus P; Moreira I
    Arq Bras Cardiol; 2015 Aug; 105(2):139-44. PubMed ID: 26269958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ratio of alpha-galactosidase to beta-glucuronidase activities in dried blood for the identification of female Fabry disease patients.
    Lukacs Z; Keil A; Kohlschütter A; Beck M; Mengel E
    J Inherit Metab Dis; 2005; 28(5):803-5. PubMed ID: 16151917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prevalence of Fabry Disease in Patients with Chronic Kidney Disease in Turkey: The TURKFAB Study.
    Turkmen K; Guclu A; Sahin G; Kocyigit I; Demirtas L; Erdur FM; Sengül E; Ozkan O; Emre H; Turgut F; Unal H; Karaman M; Acıkel C; Esen H; Balli E; Bıtırgen G; Tonbul HZ; Yılmaz MI; Ortiz A
    Kidney Blood Press Res; 2016; 41(6):1016-1024. PubMed ID: 28006774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital microfluidic platform for multiplexing enzyme assays: implications for lysosomal storage disease screening in newborns.
    Sista RS; Eckhardt AE; Wang T; Graham C; Rouse JL; Norton SM; Srinivasan V; Pollack MG; Tolun AA; Bali D; Millington DS; Pamula VK
    Clin Chem; 2011 Oct; 57(10):1444-51. PubMed ID: 21859904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is left ventricular hypertrabeculation/ noncompaction a cardiac manifestation of Fabry's disease?
    Stöllberger C; Finsterer J; Voigtländer T; Slany J
    Z Kardiol; 2003 Nov; 92(11):966-9. PubMed ID: 14634768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.